Lamotrigine Tablet
Product Images NDC 62332-038

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 62332-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lamotrigine Str)

Chemical structure diagram of the active ingredient Lamotrigine, depicting its molecular formula with chlorine and nitrogen atoms arranged in a triazine ring and phenyl substituents.*

FDA Label Image

Figure 1 (Lamotrigine Figure1)

A Kaplan-Meier failure probability curve chart comparing placebo and Lamotrigine tablets over weeks. The vertical axis shows failure probability (%) from 0 to 100, and the horizontal axis shows the duration in weeks, up to 100 weeks. The chart includes censored data points marked with plus signs for both placebo and Lamotrigine groups.*

FDA Label Image

Figure 2 (Lamotrigine Figure2)

A Kaplan-Meier failure probability curve comparing Lamotrigine tablets and placebo over weeks. The Y-axis shows failure probability percentage from 0 to 100%, and the X-axis shows time in weeks from 0 to 80. Two distinct survival curves are labeled for placebo and Lamotrigine tablets, with censored data points marked.*

FDA Label Image

Tablets Description (Lamotrigine Descri)

This image shows a chart describing four variations of Lamotrigine tablets by Alembic Pharmaceuticals Inc. It details four strengths: 25 mg capsule-shaped tablets with 'L121' debossing, and round tablets with debossing codes 'L122' for 100 mg, 'L123' for 150 mg, and 'L124' for 200 mg. All tablets are white to off-white in color.*

FDA Label Image

30 Tablets (Lamotrigine 25 Tab)

Lamotrigine Tablets USP 25 mg oral tablets label showing packaging information for a 30-tablet supply. The label includes storage instructions, manufacturer details (Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA), and directions for dispensing the medication guide. The NDC number 62332-037-30 is displayed along with barcode and regulatory text.*

FDA Label Image

30 Tablets (Lamotrigine 100)

Lamotrigine Tablets USP 100 mg oral tablets packaging label by Alembic Pharmaceuticals Inc. The label indicates 30 tablets per package with NDC 62332-038-30. It includes storage instructions, manufacturing details for Alembic Pharmaceuticals Limited in India, and Alembic Pharmaceuticals, Inc. in the USA. The label also features a barcode and medication guide note for pharmacists.*

FDA Label Image

30 Tablets (Lamotrigine 150)

Lamotrigine Tablets USP 150 mg oral tablets label with 30 tablets per package. The label includes dosage strength, manufacturer information for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA, storage instructions, and a barcode. It also contains a note for pharmacists to dispense the Medication Guide to patients and indicates the package is child-resistant.*

FDA Label Image

30 Tablets (Lamotrigine 200)

Label for Lamotrigine Tablets USP 200 mg oral tablets, containing 30 tablets per package, marketed by Alembic Pharmaceuticals Inc. The label displays dosage strength prominently in orange and white. It includes storage instructions, manufacturer details from Alembic Pharmaceuticals Limited in India, and notes that the package is child-resistant. The label also provides NDC 62332-040-30 and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.